Early Access — free while we kick the tires
EdgarHawk

FMC FMC CORP Insider Trading

6 filings analyzed · Latest 2026-03-05
Insider buys
6
Insider sells
0
Unique insiders
5
Direction
Net buying

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗

March 2026
2026-03-05
high
18,072 shares
$249,938
@ $13.83
Significance 5/10

Director Barry Michael F purchased 18,072 shares (18.1K) of FMC at $13.83 on 2026-03-04, raising holdings by 1157.0% to 19.6K shares as company faces -$569.3M net loss and -18.3% revenue decline.

Barry Michael F, a Director, executed a significant open-market purchase of 18,072 shares at $13.83, increasing his holdings from 1,562 to 19,634 shares—a 1157.0% increase in position size. The transaction occurs in a deeply stressed fundamental environment: FMC posted a net loss of $-569.3M in its latest full fiscal year, revenue contracted 18.3% year-over-year, and the stock trades at $14.29, down 67.8% from its 52-week high of $44.45. The purchase price of $13.83 sits near the 52-week low of $12.18, yet well below current valuations, suggesting the insider acted when valuation was markedly depressed. However, this buy must be weighed against FMC's persistent unprofitability, steep revenue decline, and severely diminished market cap of $1.8B, which collectively signal material operational and financial stress rather than a recovery signal.

November 2025
2025-11-14
medium
7,000 shares
$96,390
@ $13.77
Significance 4/10

FMC Director John Mitchell Raines buys 7,000 shares at $13.77 amid -77.1% drawdown from 52-week high; stock down -53.8% in 30 days.

John Mitchell Raines, a Director of FMC, purchased 7,000 shares at $13.77, more than doubling his holdings to 13.8K shares from 6.8K shares. The transaction occurs as FMC trades -77.1% below its 52-week high of $60.62 and has fallen -53.8% over the prior 30 days and -62.9% over 90 days. In parallel, FMC reported a latest-quarter net loss of -$569.3M against revenue of $542.2M, with annual revenue declining -5.4% year-over-year. The buy occurs at a depressed price level during a period of acute operational stress and heavy equity value destruction. This director's decision to accumulate shares at such a discount, despite deteriorating earnings and recent sharp declines, provides a data point on insider appetite for the company's future, though the motivation remains latent in the filing alone.

2025-11-07
medium
10,000 shares
$135,957
@ $13.60
Significance 4/10

Director Carol Anthony Davidson buys 10,000 shares of FMC at $13.60 amid 60.9% 90-day decline; stock down -78.0% from 52-week high

Director Carol Anthony Davidson purchased 10,000 shares of FMC on 2025-11-05 at $13.60, increasing holdings by 75.6% to 23,227 shares total. The timing coincides with severe price weakness: the stock has fallen -60.9% over 90 days and trades -78.0% below its 52-week high of $63.62, currently at $13.99. FMC's fundamentals are challenged, with latest quarterly revenue of $542.2M, negative net income of $-569.3M, and annual revenue contraction of -5.4%. Notably, Davidson's prior purchase at this ticker on 2025-03-05 showed a +7.7% 90-day return, marking it as well-timed in that instance. However, the current buy into extreme weakness and deteriorating financials requires scrutiny of whether this represents conviction or reflects limited discretionary context.

March 2025
2025-03-06
high
6,000 shares
$223,987
@ $37.33
Significance 6/10

Director Carol Anthony Davidson buys 6,000 FMC shares at $37.33 as part of 3-insider cluster buy within 14 days

Director Carol Anthony Davidson purchased 6,000 shares at $37.33 on 2025-03-05, establishing a position from zero shares. This purchase is part of a cluster pattern with 2 other insiders buying FMC within the past 14 days, which suggests aligned insider activity. The stock currently trades at $40.26, down -25.5% over 30 days and -28.8% over 90 days, placing it -40.4% from its 52-week high of $67.53. The company's latest quarter revenue of $1,065,400,000.00 and P/E of 10.57 provide context for valuation, though annual revenue growth is negative at -5.4%. The coordinated timing of multiple insiders entering or adding positions during a significant price decline merits closer examination of management's view on near-term prospects.

2025-03-05
medium
President, FMC
5,600 shares
$200,340
@ $35.78
Significance 4/10

FMC President Pereira Ronaldo bought 5,600 shares at $35.78 on 2025-03-04; stock down 41.6% from 52-week high, cluster buy detected with 2 other insiders in 14 days

Pereira Ronaldo, FMC's President, purchased 5,600 shares at $35.78, increasing his holdings by 13.0% to 48.8K shares. The transaction occurs against a backdrop of material price weakness: the stock has fallen 41.6% from its 52-week high of $67.53 and is down 28.2% over the past 30 days. A cluster pattern has emerged with 2 other insiders also buying within the past 14 days, suggesting coordinated conviction at lower valuations. However, Pereira's own prior buy at FMC on 2023-09-13 resulted in negative returns over both 30 days (-17.4%) and 90 days (-27.7%), raising caution about historical timing accuracy. The company's fundamentals show contraction: annual revenue growth stands at -5.4%, though the valuation appears compressed at P/E 10.35. The convergence of multiple insider purchases during a significant drawdown and revenue headwinds warrants close investor attention to whether this reflects deep-value conviction or structural concerns that may continue.

2025-03-04
high
Chairman and CEO
54,000 shares
$1,938,449
@ $35.90
Significance 7/10

FMC CEO Brondeau buys 54,000 shares at $35.90 as stock down -38.0% in 90 days

BRONDEAU PIERRE R, Chairman and CEO of FMC CORP, purchased 54,000 shares at $35.90 on 2025-03-04, increasing his holdings from 244,439 to 298,439 shares (+22.1%). The purchase occurred during a period of significant price weakness: FMC is trading at $36.60 (current), down -45.8% from its 52-week high of $67.53 and down -38.0% over 90 days. The company's fundamentals show revenue of $1,065,400,000.00 with annual growth declining -5.4%, though the P/E of 9.61 reflects low valuation relative to historical levels. A CEO's material equity purchase of this magnitude during sharp drawdown warrants investor attention, particularly given the revenue headwinds and the stock's distance from recent highs. The transaction should be monitored against whether operational trends stabilize or continue deteriorating.

More Chemicals and Allied Products companies

Get alerts for FMC

Add FMC to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access